# Study on Autologous Osteoblastic Cells Implantation to Early Stage Osteonecrosis of the Femoral Head

> **NCT01529008** · PHASE3 · TERMINATED · sponsor: **Bone Therapeutics S.A** · enrollment: 68 (actual)

## Conditions studied

- Osteonecrosis of the Femoral Head

## Interventions

- **DRUG:** Core decompression/PREOB® implantation
- **DRUG:** Core decompression/placebo implantation

## Key facts

- **NCT ID:** NCT01529008
- **Lead sponsor:** Bone Therapeutics S.A
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-11
- **Primary completion:** 2017-05
- **Final completion:** 2018-11
- **Target enrollment:** 68 (ACTUAL)
- **Why stopped:** the interim results suggest that it is unlikely that the primary objective will be achieved at the final analysis
- **Last updated:** 2022-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01529008

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01529008, "Study on Autologous Osteoblastic Cells Implantation to Early Stage Osteonecrosis of the Femoral Head". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01529008. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*